During public health emergencies, such as pandemics, the FDA can issue an Emergency Use Authorization (EUA) for medical products that have not yet received formal approval. The EUA allows for the use of vaccines, treatments, and diagnostic tests that demonstrate potential benefits outweighing the risks, based on available evidence. This mechanism helps provide timely access to essential medical solutions during crises.